TRZ
TRZ is a synthetic 39-amino acid dual-receptor peptide targeting both the GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor pathways. Supplied as a lyophilized powder in a 3mL vial, it is intended exclusively for in vitro laboratory research by qualified scientific personnel.
This peptide has been utilized in preclinical studies examining dual-incretin receptor binding, glucose metabolism signaling, pancreatic beta cell function, and energy substrate regulation — independent of the broader hormonal mechanisms associated with endogenous incretin activity.
Product Details
- Form: Lyophilized powder (for laboratory research)
- Amounts: 8 mg, 10 mg, 15 mg, 20 mg, 30 mg, 60 mg or 70 mg per vial
- Purity: ≥ 98% (HPLC tested)
- Sequence: 39–amino acid GLP-1/GIP dual agonist analogue
- Molecular Formula: C₂₂₅H₃₆₆N₆₄O₆₇
- Molecular Weight: ~4813 Da
- Intended Use: Laboratory research only
DISCLAIMER: This product is strictly to be used for scientific research use only. It is not for human consumption and the FDA has not approved the use for diagnostic, therapeutic, or medical purposes.
We recommend you review our Terms of Service if you have questions about product use.
